Histatin-5 Based Synthetic Peptides and Uses Thereof
AssigneesUniversity of Maryland, Baltimore, University of Maryland, College Park
InventorsMary Ann Jabra-Rizk, Amy J. Karlsson, Svetlana Pavlova Ikonomova
Life of this patent
Estimating the term…
Loading patent…
AssigneesUniversity of Maryland, Baltimore, University of Maryland, College Park
InventorsMary Ann Jabra-Rizk, Amy J. Karlsson, Svetlana Pavlova Ikonomova
Estimating the term…
Provided herein are synthetic peptides or synthetic fragments thereof based on a Histatin-5 peptide, for example with a sequence DSHAKRHHGYKRKFHEKHHSHRGY (SEQ ID NO: 1). The synthetic peptides or synthetic fragments have at least one substituted amino acid that is arginine and/or leucine to increase resistance to proteolytic degradation by a microbe, such as a fungus. The synthetic peptides or synthetic fragments thereof may be contained in a hydrogel. Also provided are methods for treating or preventing a pathophysiologica condition via topical administration of the synthetic peptide or fragments. The pathophysiological condition may be a fungal or bacterial infection including associated inflammation or a chronic condition.
A synthetic peptide or synthetic fragment thereof, comprising:
A synthetic peptide resistant to proteolysis by Candida albicans enzymes having a sequence shown in SEQ ID NO:
Dependencies are inferred from the claim text.